eBlu Solutions has established itself as a dependable partner for healthcare institutions seeking to utilize technology for improved patient care, operational efficiency, and positive outcomes. With a comprehensive suite of solutions, the company enables healthcare providers to optimize workflows, enhance resource efficiency, and deliver exceptional patient care. The addition of pharmacy benefit support highlights the company’s dedication to maintaining its rapid growth. This new feature includes real-time pharmacy benefit investigations and prior authorization support for sponsored products within the system.
“We are delighted to unveil our extensive pharmacy benefit support on the eBlu Solutions platform,” said Nathan Fornwalt, Co-Founder and Chief Technical Officer for eBlu Solutions. “This workflow is designed to simplify the process for healthcare providers, ensuring patients receive timely access to their prescribed medications while navigating the complexities of insurance coverage and benefits. By offering upfront visibility into pharmacy networks and benefit coverage, and facilitating electronic prior authorization and appeals, we eliminate unnecessary delays and confusion that often accompany prescription fulfillment. Our unified platform now supports both physician-administered and patient-administered therapies, making it a one-stop shop for efficient patient treatment clearance across both medical and pharmacy benefits.”
For media inquiries or further information, please visit the eBlu Solutions’ website.
About eBlu Solutions
eBlu Solutions provides a secure single-portal software platform for electronic prior authorization and benefits verification in the infusion-based specialty medication space. eBlu Solutions aims to streamline the fragmented nature of the approval process for specialty medication treatments, and currently supports a variety of specialties including rheumatology, retina, neurology, gastroenterology, and allergy & asthma.
One hospital found that patients spent 65,000 more days in inpatient hospitals than needed. Additionally, hospital visits have surpassed pre-pandemic levels, and clinicians, especially nurses, are experiencing burnout, leading them to leave their professions. In response, innovative strategies are emerging that aim to deliver care to patients at home using advanced technology and by reimagining the care delivery model to ease the burden on traditional healthcare facilities and improve quality of care.
This webinar will educate the attendees and raise awareness about how innovative tech-enabled, care-at-home solutions can help strategically address the challenges of inpatient capacity strain, staffing, and increased hospital length of stay (LOS).
Register for this webinar today to gain insights about acute to transitional to post-acute care-at-home programs and novel strategies to navigate the current healthcare landscape.
Join Tahir Haque (Moderator), MD, Senior Medical Director, Biofourmis; Physician, Brigham and Women’s Hospital; Patrick McGill, MD, MBA, FAAFP, EVP, Chief Transformation Officer, Community Health Network; Scott Harrison, DO, MBA, Regional Chief Medical Officer, Appalachian Regional Healthcare; and Jody Goodling, PharmD/MBA, Director of Continuing Care Services, WellSpan Health, for the live webinar on Friday, September 20, 2024, at 1pm EDT (10am PDT).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
“We were extremely happy to learn about an electronic version of the M.I.N.I.,” says Dr. Andres Lehtmets. “The addition of Proem and use of the digital M.I.N.I. is a wonderful opportunity for us to improve how we assess our patients.”
Estonia, like most countries, has seen a rise in the number of people seeking mental health care. This growing demand has prompted an increase in funding toward mental health from the country’s single payer healthcare system, including money for innovation projects. The hospitals applied for and received innovation project funding that went toward adding Proem.
Richard Jalakas, IT project manager of Tartu University Hospital, says moving to the digital M.I.N.I. is helping address a significant challenge across the hospitals: different approaches to how mental illness is assessed. “The electronic M.I.N.I. is a great tool because it covers many potential mental health illnesses and brings consistency to our assessments,” Jalakas says. “The automatic scoring helps decrease a lot of errors, and report generation is so fast and easy compared to the paper and PDF versions.”
Jalakas says he also appreciates the effort of the Proem team to make adoption of the platform and digital M.I.N.I. simple. While the Proem user interface is in English, the assessments have been translated into Estonian and can be translated to any language at the request of a client. “The system is so accessible for our nurses, and there’s never been any downtime,” he says. “Whenever we have questions, we get answers very quickly.”
“Estonia is at the forefront of health care technology innovation, having been the first country to implement a nationwide electronic health record system,” says John Letter, chief executive officer of Proem. “We are pleased that these hospitals identified Proem as a progressive solution that supports their goals of improving the diagnosis and treatment of mental illness. Our team looks forward to continuing to support Estonia as the platform is rolled out across the country and ensuring Proem is empowering the hospitals’ clinical staff to strengthen the delivery of mental health care.”
ABOUT PROEM BEHAVIORAL HEALTH Proem Behavioral Health provides the premier clinical workflow software engine that helps health care providers, substance use disorder clinics and research organizations efficiently and accurately screen, test and measure treatment success for those suffering from mental illness. Proem is the exclusive digital licensee worldwide of gold-standard, evidence-based screening solutions, structured interviews and post-diagnosis severity measurement scales to monitor patient outcomes. To learn more, visit proemhealth.com and follow Proem on LinkedIn.
This year’s event covers Cellular Structures and Functions, Advanced Microscopy Techniques, Cell Signaling Pathways, Emerging Methodologies in Cell Biology, Innovations in Cell Culture Techniques, and Cell Death and Autophagy.
Event Highlights:
Live keynote presentation by Mark Bryniarski, PhD, MS, Principal Scientist, PKDM, Amgen, speaking on the “Applications of Cellular Assays for Understanding Drug Disposition of Protein Therapeutics” with a live Q & A.
Live keynote presentation by Sabrina Absalon, PhD, Assistant Professor, Indiana University School of Medicine, speaking on “Exploring Plasmodium Parasite Cell Division Processes through Expansion Microscopy Visualization” with a live Q&A
Speakers from academia and industry leading on-demand presentations into super-resolution microscopy, fibroblast growth factors in humanized mouse models, organ-on-a-chip systems, MAPK pathways, and microphysiological systems.
A virtual poster session and Poster Discussion Hour between (10:00am-11:00am PDT) offering attendees the opportunity to present their research to a global audience, with submission being free of charge.
“We are proud to be hosting the 8th Annual Cell Biology Virtual Event Series showing our dedication to novel research breakthroughs and our company mission to improve scientific collaboration and learning and are excited about the invited speakers and upcoming presentations,” says Greg Cruikshank, who is the CEO at Labroots. This year, Labroots also welcomes sponsors Thermo Fisher Scientific, DASGIP an Eppendorf Company, ABSA International, and Chati, each exhibiting in the virtual exhibit hall or speaking at the event.
Labroots leverages the Chati virtual event platform to offer an interactive, immersive educational digital experience. Attendees will be able to explore the lobby, allowing navigation to various virtual spaces, click into the auditorium to watch live and on-demand webinars, view posters within the poster hall, and take part in the event gamification, racking up points highlighted on the event leaderboard. By attending this event, you can earn 1 P.A.C.E. Continuing Education credit per presentation for a maximum of 30 credits.
Save your seat for this free event by clicking here. Participants can use the official hashtag #LRcellbio to follow the conversation and connect with other members in the cell biology community! Follow @CellBiology_LR on X and @CellandMolecularBiology.LR on Facebook to connect Cell & Molecular Biology community and stay up to date with the latest trending science news.
About Labroots Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars, and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.
With 16 independent signal outputs, MiniSim EEG 2000 makes it easy for healthcare professionals to confirm the precision of various EEG monitoring devices, including recorders, sleep study monitors, and multi-channel EEG monitoring systems. This, in turn, facilitates the accurate monitoring, diagnosis, and treatment of patients.
“We have been serving the biomedical community worldwide since 1987, and we are excited to add MiniSim EEG 2000 to our growing line of patient simulators,” said Dr. Mohan Das, founder and CEO of Netech Corporation. “This one-of-a-kind instrument highlights our commitment to providing the biomedical community with reliable instruments for the accurate testing and calibration of various patient care equipment.”
Netech Corporation’s revolutionary EEG simulator is also capable of measuring electrocardiogram (ECG) waveforms, along with performance waveforms, such as sine, square and triangle. The unit serves the critical function of helping ensure that the EEG machine being used for patients is in tolerance, which further enhances the value of the company’s patient simulator in the marketplace.
MiniSim EEG 2000 is one of the most advanced and versatile patient simulators on the market today. The device is distinguished by its compact, lightweight, user-friendly design and impressive functionality. MiniSim EEG 2000’s display incorporates a high-contrast 128 X 64 LCD with LED backlighting for easy viewing. Its keypad features soft-touch tactile buttons that offer dedicated key functions. It also has an interactive menu-driven interface that makes it easy for users to select from a variety of functions. In addition, the product has patented EEG cup electrodes that are simple to hook up, and it operates on a rechargeable battery, making it ideal for performance testing all EEG instrumentation.
Patient simulators—also referred to as physiological simulators or vital sign rhythm generators—are invaluable tools for biomedical personnel to accurately evaluate and verify the performance of patient monitoring systems. Essentially, a human patient simulator mimics physiological parameters, such as ECG, arrhythmia waveforms, blood pressure, respiration and temperature. Netech Corporation currently offers four different models of patient simulators, with MiniSim EEG 2000 being the latest creation in this important group of devices.
Netech Corporation has a strong reputation for creating high-quality medical equipment testing products like MiniSim EEG 2000. It is committed to manufacturing state-of-the-art products that satisfy the evolving technological needs and standards of the medical industry. All of the company’s medical testing products—which are made in the United States—are tested, calibrated according to the ISO 9001 quality management system, and comply with National Institute of Standards and Technology (NIST) guidelines. In addition, each of its products comes with a NIST certificate of calibration and is backed by a two-year warranty, excellent customer service, and outstanding technical support.
For more information about Netech Corporation and its new MiniSim EEG 2000 patient simulator, please visit www.netechbiomedical.com or contact Global Sales and Marketing Manager Steven Gonzalez at [email protected].
About Netech Corporation
Based in Farmingdale, N.Y., Netech Corporation has been designing and manufacturing innovative biomedical and industrial test equipment since 1987. Its mission is to provide the biomedical industry with the highest quality medical equipment testing instruments and knowledge that fulfill their wants and needs at the right price. As such, Netech Corporation strives to empower the biomedical industry by manufacturing easy-to-use test instruments while leading the way with innovation and ultimate customer satisfaction. The company produces a broad array of affordable biomedical test instruments, including digital pressure/vacuum meters and gauges, patient simulators, electrical safety analyzers, defibrillator analyzers, cardiac output simulators, and EEG simulators.
To enhance healthcare accessibility and support primary care expansion in underserved communities, Rural Healthcare Group announces the formal rebranding of 4 clinics to Crossroads Medical Group.
NASHVILLE, Tenn., Sept. 5, 2024 /PRNewswire-PRWeb/ — To enhance healthcare accessibility and support primary care expansion in underserved communities, Rural Healthcare Group announces the formal rebranding of 4 clinics to Crossroads Medical Group: Pleasant View Primary Care, Springfield Primary Care, White House Primary Care and Family Health Center of Ashland City.
With this rebrand, Crossroads Medical Group, under the umbrella of Rural Healthcare Group, will now encompass 10 clinics across Middle Tennessee, serving 50,000+ unique patients annually. While Crossroads Medical Group partnered with Rural Healthcare Group in August 2023, the group has delivered high-quality, personalized primary care to underserved communities in Middle Tennessee for over 20 years.
Founded in 2022 to improve the lives of people living in underserved areas through high-quality primary care, Rural Healthcare Group has grown to a network of nearly 50 providers across Tennessee and North Carolina.
“Our rebranding initiative reflects our ongoing commitment to provide exceptional primary care in underserved communities,” said Benson Sloan, CEO at Rural Healthcare Group. “Under the recognizable Crossroads Medical Group name, we will continue to deliver the same trusted care that our patients expect, with enhanced access to comprehensive primary healthcare services and additional resources across our growing network of clinics and providers.”
Starting as a single-location clinic in White House, Tennessee, Crossroads Medical Group has evolved into a multi-location healthcare leader in the Middle Tennessee community offering a wide range of services, including primary care, walk-in care, and certain specialist healthcare services.
“The partnership with Rural Healthcare Group has brought greater access to high-quality care to the Crossroads Medical Group communities,” said Dr. Scott Jordan, co-founder of Crossroads Medical Group. “This brand expansion is an exciting development that ensures our patients benefit from enhanced services and also helps support further clinic expansion in Tennessee.”
About Rural Healthcare Group
Rural Healthcare Group (RHG) partners with primary care providers in rural America to optimize their practices, improve their experience, and ensure their legacies. RHG’s vision is to build the nation’s most esteemed group of rural primary care practices. RHG was founded in 2022 and is headquartered in Nashville, Tennessee.
Sleep Better Solution offers ProSomnus, a highly advanced oral appliance that eases the symptoms of obstructive sleep apnea. The device fits like a dental mouthguard, providing a smooth and comfortable fit. ProSomnus holds the lower jaw forward and opens the airway to prevent obstruction.
ProSomnus helps with obstructive sleep apnea symptoms and snoring. It improves airflow during sleep, assisting patients in resting without constant interruptions. The device may also improve morning headaches, irritability, and exhaustion, allowing the patient and their partner to sleep well. It provides these benefits without a bulky external device, making treatment portable and convenient.
Medical insurance may cover sleep apnea solutions. Sleep Better Solution works closely with insurers and offers flexible payment plans. and also participates in Medicare, allowing services to be accessible to more patients.
Dr. Steven Liao, one of New Jersey Monthly’s Top Dentists and a member of the International Academy of Sleep, is a highly skilled and experienced practitioner. He received his Doctor of Dental Medicine degree from the University of Medicine and Dentistry of New Jersey.
Dr. Liao is excited about introducing these new services, “Among my dental patients, I discovered a need for sleep apnea treatment. Many patients cannot or do not want to use CPAP machines and need a less invasive alternative. Offering the ProSomnus appliance allows these patients and their families to sleep better and protect their health.”
Services Offered
Sleep Apnea Risk Assessment: As part of the assessment, an intraoral scanner is used to take 3D digital impressions which are used to assist the doctor in designing an oral appliance.
ProSomnus Oral Appliance: This device fits seamlessly into a sleep routine without the hassle of a machine.
About Sleep Better Solution
Sleep Better Solution provides obstructive sleep apnea treatment in Lodi, NJ. Dr. Liao provides the ProSomnus oral appliance to relieve sleep issues. The practice is conveniently located at 147 Main Street, Suite #7 Lodi, NJ 07644, and may be contacted online at https://www.sleepbettersolutionnow.com, or by calling 862-208-2112.
According to the Lymphatic Education & Research Network, an estimated 1 in every 1,000 people in the United States suffers from lymphedema. Among cancer survivors, the prevalence is higher, with about 20-40% of breast cancer survivors developing lymphedema, particularly post-surgery and radiation therapy. The economic impact of lymphedema includes direct medical costs for treatment and indirect costs such as lost productivity.
Dr. Andrew Elkwood, practicing surgeon and founder of The Institute for Advanced Reconstruction stated, “Dr. Dayan’s arrival marks a significant milestone for patients seeking advanced treatment options for lymphedema, a condition that poses significant challenges for individuals, particularly those undergoing breast cancer treatment. While lifelong compression and physiotherapy have been standard treatment approaches, many patients continue to experience disease progression despite their compliance. Dr. Dayan’s expertise offers hope for those in need of alternative solutions.”
“Joining The Institute for Advanced Reconstruction and establishing The Institute for Lymphatic Surgery and Innovation will offer patients suffering from lymphedema a new option for care that will feature state-of-the-art techniques with use of some of the newest technology and instruments in the world,” said Dr. Dayan. “Our established presence in NJ and partnerships with some of the most well-known reconstructive surgery practices throughout the United States will offer patients new innovative options for care of this prevalent disease.”
In addition to assembling a clinical team of experts in lymphatic surgery, The Institute for Lymphatic Surgery and Innovation purchased a Mitaka microscope, the highest resolution microscope available designed specifically for intricate procedures such as lymphatic surgery, allowing surgeons to visualize and operate on lymphatic vessels with exceptional clarity and precision. Other advanced instruments being used at The Institute include an ultra-high frequency ultrasound and ICG lymphangiography, further enhancing specific care for patients.
Dr. Dayan began seeing patients from around the world and performed the first lymphatic surgery at The Valley Hospital on August 16th. The surgery included immediate lymphatic reconstruction using lymphovenous bypass to reduce the risk of lymphedema at the time of axillary dissection.
Dr. Dayan’s surgical contributions extend to several areas. For breast reconstruction, he utilizes techniques that use the patient’s own tissue, including DIEP, GAP, and PAP flaps. Notably, Dr. Dayan pioneered the DUG flap technique, expanding treatment options for a broader range of patients. Dr. Dayan has extensive microsurgical experience utilizing a range of techniques to reanimate the face due to facial paralysis from conditions like parotid cancer, acoustic neuroma, Bell’s Palsy and developmental facial paralysis. He is an expert in surgical planning that utilizes nerve transfers, grafts and muscle transfers to restore function and quality of life to patients with facial paralysis.
Prior to joining The Institute, Dr. Dayan spent 10 years at Memorial Sloan Kettering Cancer Center, where he established lymphatic surgery and facial nerve programs, and honed his skills through an esteemed fellowship in advanced microsurgical reconstruction at the renowned Chang Gung Memorial Hospital in Taiwan.
Dr. Dayan was honored with the prestigious Godina Traveling Fellowship in recognition of his significant contributions to microsurgery. With over 100 peer-reviewed publications, numerous book chapters, and his recent editorial work on a textbook dedicated to lymphedema, Dr. Dayan continues to advance knowledge and understanding in his areas of expertise. He serves as the founding president of the American Society for Lymphatic Surgery and has been a dedicated board member of the Lymphatic Education and Research Network for over a decade.
Dr. Dayan has been recognized with several prestigious awards, including Castle Connolly’s America’s Top Doctor in 2024, Top Doctor in the New York Metro Area in 2023, and national and regional Top Doctor in New York Magazine from 2016 to 2020.
Dr. Dayan is currently seeing patients in Westwood, NJ. For more information or to schedule a consultation, please visit www.AdvancedReconstruction.com or call 833-598-2417.
About the Institute for Advanced Reconstruction
The Institute specializes in advanced reconstructive surgery and innovative healthcare solutions. Our expert team addresses numerous conditions, ranging from cancer-related diseases and hand trauma to peripheral nerve disorders. Based on an academic, collaborative care approach, we bring together the specialized training and expertise of the country’s finest surgeons and medical teams to deliver transformative results.
With clinics across the country, The Institute attracts patients from around the globe by providing access to the world’s most accomplished doctors, state-of-the-art surgical techniques, and advanced medical technologies. We are dedicated to cutting-edge research and advancing medical frontiers, persistently raising the bar on what is possible in reconstructive healthcare.
Linda Skolnik, Co-owner of Assisting Hands The Villages, is honored to be the recipient of Rotary Vocational Service Award.
THE VILLAGES, Fla., Sept. 1, 2024 /PRNewswire-PRWeb/ — Linda Skolnik, Co-owner of Assisting Hands The Villages, is honored to be the recipient of Rotary Vocational Service Award, a recognition that highlights community members’ commitment to serving others. This award is given to individuals who uphold high ethical standards in their vocation, make a meaningful impact to the community, and actively use their talents to address the needs of those around them.
“I’m thrilled and honored to be recognized by my fellow Rotarians with the Vocational Service Award. I’m grateful to be able to get up every day and help others both personally and professionally.”
The Rotary Vocational Service Award is a celebration of those who exemplify the best in their vocation, using their skills to serve others and make a lasting impact. It serves as a reminder of the power of service, integrity, and dedication in creating positive change within the community.
Linda has also accepted the President-Elect nomination for the Rotary Club of The Villages (Morning Club) for 2024-2025.
“We are honored to be recognized as a top employer by both our dedicated staff and the greater Maryland community. This accolade highlights the distinctive culture and compassionate care that define Mercy,” said Dr. David N. Maine, President and CEO, Mercy Health Services. “On behalf of the Sisters of Mercy, our leadership team, and myself, I’d like to thank our physicians, providers, nurses, and all Mercy team members. Your commitment makes Mercy a remarkable place to work and a beacon of hope and healing for the Baltimore area and beyond.”
The survey, conducted by the market research firm Statista, asked participants how likely they were on a scale of zero to 10 to recommend their employer as a good place to work. Respondents were also asked to evaluate employers they’d worked for within the past two years, and organizations they knew within their industry or through friends or family who worked there. Workers from all 50 states and the District of Columbia answered the most recent survey. Those findings were supplemented with data from the previous three surveys. In all, 1,294 organizations made the final cut.
Forbes has recognized Mercy in the past, naming the 150-year-old hospital among the top 400 mid-size employers in the U.S. in 2017, 2018, 2019, 2022 and 2024.
Founded in 1874 by The Sisters of Mercy, Mercy Medical Center is a university-affiliated Catholic hospital with a national reputation for women’s health and orthopedics. Mercy is home to the acclaimed Weinberg Center for Women’s Health & Medicine, and the $400+ million, 20-story Mary Catherine Bunting Center. For more information about Mercy, visit http://www.mdmercy.com, MDMercyMedia on Facebook and Twitter(X), http://www.youtube.com/mmcbaltimore, or call 1-800-M.D.-Mercy.
